Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Harald F. Langer - , National Institutes of Health (NIH), Eberhard Karls Universität Tübingen (Autor:in)
  • Kyoung Jin Chung - , Institut für Physiologie, Medizinische Klinik und Poliklinik III, National Institutes of Health (NIH) (Autor:in)
  • Valeria V. Orlova - , National Institutes of Health (NIH) (Autor:in)
  • Eun Young Choi - , National Institutes of Health (NIH) (Autor:in)
  • Sunil Kaul - , National Institutes of Health (NIH) (Autor:in)
  • Michael J. Kruhlak - , National Institutes of Health (NIH) (Autor:in)
  • Markella Alatsatianos - , National Institutes of Health (NIH) (Autor:in)
  • Robert A. DeAngelis - , University of Pennsylvania (Autor:in)
  • Paul A. Roche - , National Institutes of Health (NIH) (Autor:in)
  • Paola Magotti - , University of Pennsylvania (Autor:in)
  • Xuri Li - , National Institutes of Health (NIH) (Autor:in)
  • Matina Economopoulou - , Klinik und Poliklinik für Augenheilkunde, National Institutes of Health (NIH) (Autor:in)
  • Stavros Rafail - , University of Pennsylvania (Autor:in)
  • John D. Lambris - , University of Pennsylvania (Autor:in)
  • Triantafyllos Chavakis - , National Institutes of Health (NIH) (Autor:in)

Abstract

Beyond its role in immunity, complement mediates a wide range of functions in the context of morphogenetic or tissue remodeling processes. Angiogenesis is crucial during tissue remodeling in multiple pathologies; however, the knowledge about the regulation of neovascularization by the complement components is scarce. Here we studied the involvement of complement in pathological angiogenesis. Strikingly, we found that mice deficient in the central complement component C3 displayed increased neovascularization in the model of retinopathy of prematurity (ROP) and in the in vivo Matrigel plug assay. In addition, antibody-mediated blockade of C5, treatment with C5aR antagonist, or C5aR deficiency in mice resulted in enhanced pathological retina angiogenesis. While complement did not directly affect angiogenesis-related endothelial cell functions, we found that macrophages mediated the antiangiogenic activity of complement. In particular, C5a-stimulated macrophages were polarized toward an angiogenesis-inhibitory phenotype, including the upregulated secretion of the antiangiogenic soluble vascular endothelial growth factor receptor-1. Consistently, macrophage depletion in vivo reversed the increased neovascularization associated with C3-or C5aR deficiency. Taken together, complement and in particular the C5a-C5aR axes are potent inhibitors of angiogenesis.

Details

OriginalspracheEnglisch
Seiten (von - bis)4395-4403
Seitenumfang9
FachzeitschriftBlood
Jahrgang116
Ausgabenummer22
PublikationsstatusVeröffentlicht - 25 Nov. 2010
Peer-Review-StatusJa

Externe IDs

researchoutputwizard legacy.publication#36331
researchoutputwizard legacy.publication#36904
Scopus 78649482676
PubMed 20625009

Schlagworte